Literature DB >> 12860355

Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders.

Peter R Joyce1, Geraldine R Rogers, Allison L Miller, Roger T Mulder, Suzanne E Luty, Martin A Kennedy.   

Abstract

We investigated whether polymorphisms of the dopamine D4 receptor (DRD4) and polymorphisms of the dopamine D3 receptor (DRD3) were associated with personality disorder symptomatology rather than with personality traits such as novelty seeking. DNA was obtained from 145 depressed patients in a clinical trial. These patients were assessed for the presence of personality disorder symptoms and disorders. The 2-repeat allele of the DRD4 exon III polymorphism was associated with increased rates of avoidant and obsessive personality disorder symptomatology. The T,T genotype of the DRD4 -521 C>T polymorphism was also associated with increased rates of avoidant and obsessive personality disorder symptomatology. The Gly9,Gly9 genotype of the DRD3 Ser9Gly polymorphism was associated with increased rates of obsessive personality disorder symptomatology. None of these three polymorphisms were associated with novelty seeking or other temperament traits on the Temperament and Character Inventory. Our results suggest that genetic polymorphisms of DRD4 and DRD3 may well be associated with personality traits, and that conflicting findings to date may arise from the problem of phenotype definition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860355     DOI: 10.1016/s0165-1781(03)00124-0

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  12 in total

1.  Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses.

Authors:  Kyu Young Lee; Eun-Jeong Joo; Yong Ick Ji; Duk-Hwan Kim; Joo Bae Park; In-Won Chung; Sang Ick Lee; Yeon Ho Joo; Yong Min Ahn; Joo Yun Song; Yong Sik Kim
Journal:  Exp Mol Med       Date:  2011-01-31       Impact factor: 8.718

Review 2.  Current Knowledge on Gene-Environment Interactions in Personality Disorders: an Update.

Authors:  Andrea Bulbena-Cabre; Anahita Bassir Nia; M Mercedes Perez-Rodriguez
Journal:  Curr Psychiatry Rep       Date:  2018-08-09       Impact factor: 5.285

Review 3.  Obsessive-compulsive personality disorder: a current review.

Authors:  Alice Diedrich; Ulrich Voderholzer
Journal:  Curr Psychiatry Rep       Date:  2015-02       Impact factor: 5.285

Review 4.  Genetic and Neuroimaging Features of Personality Disorders: State of the Art.

Authors:  Guorong Ma; Hongying Fan; Chanchan Shen; Wei Wang
Journal:  Neurosci Bull       Date:  2016-04-01       Impact factor: 5.203

Review 5.  Molecular genetics of personality.

Authors:  Kurtis L Noblett; Emil F Coccaro
Journal:  Curr Psychiatry Rep       Date:  2005-03       Impact factor: 8.081

Review 6.  Endophenotypes in the personality disorders.

Authors:  Larry J Siever
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

7.  The genetic epidemiology of personality disorders.

Authors:  Ted Reichborn-Kjennerud
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

8.  Genetic variants in dopamine pathways affect personality dimensions displayed by patients with eating disorders.

Authors:  Luz M González; Sonia Mota-Zamorano; Angustias García-Herráiz; Estefanía López-Nevado; Guillermo Gervasini
Journal:  Eat Weight Disord       Date:  2019-11-30       Impact factor: 4.652

Review 9.  Genetic influences on anxiety in children: what we've learned and where we're heading.

Authors:  Alice M Gregory; Thalia C Eley
Journal:  Clin Child Fam Psychol Rev       Date:  2007-09

10.  Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers.

Authors:  Erik G Jönsson; Jessica Bah; Jonas Melke; Rami Abou Jamra; Johannes Schumacher; Lars Westberg; Roland Ivo; Sven Cichon; Peter Propping; Markus M Nöthen; Elias Eriksson; Göran C Sedvall
Journal:  BMC Psychiatry       Date:  2004-03-04       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.